Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and Weight Loss

quinoxalines has been researched along with Weight Loss in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, D; Cheng, G; Guo, P; Hao, H; Huang, Q; Ihsan, A; Jamil, F; Luo, X; Tao, Y; Wang, X; Yuan, Z1
Cocores, JA; Gold, MS1
Wang, HL; Wang, HS; Wu, WR; Xiang, XH; Zhao, Y1
Boysen, G; Overgaard, K; Pedersen, H; Sereghy, T1
Berkhuysen, MH; Beyersbergen van Henegouwen, GM; de Vries, H; Kalloe, F1

Other Studies

5 other study(ies) available for quinoxalines and Weight Loss

ArticleYear
Evaluation of the safety of primary metabolites of cyadox: Acute and sub-chronic toxicology studies and genotoxicity assessment.
    Regulatory toxicology and pharmacology : RTP, 2016, Volume: 74

    Topics: Animals; Anti-Infective Agents; Biomarkers; Biotransformation; Dose-Response Relationship, Drug; Female; Lethal Dose 50; Liver; Male; Maximum Tolerated Dose; Mice, Inbred BALB C; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagenicity Tests; Organ Size; Quinoxalines; Rats, Wistar; Risk Assessment; Time Factors; Toxicity Tests, Acute; Toxicity Tests, Subchronic; Weight Loss

2016
Varenicline, appetite, and weight reduction.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Fall, Volume: 20, Issue:4

    Topics: Aged; Alcoholism; Benzazepines; Female; Humans; Psychiatric Status Rating Scales; Quinoxalines; Smoking Cessation; Varenicline; Weight Loss

2008
Blockade of ionotropic glutamatergic transmission in the ventral tegmental area attenuates the physical signs of morphine withdrawal in rats.
    Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:7

    Topics: Animals; Behavior, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Microinjections; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Substance Withdrawal Syndrome; Synaptic Transmission; Ventral Tegmental Area; Weight Loss

2004
Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
    Neurological research, 1993, Volume: 15, Issue:5

    Topics: Animals; Brain Edema; Cerebral Infarction; Cerebrovascular Circulation; Fibrinolysis; Intracranial Embolism and Thrombosis; Male; Paralysis; Quinoxalines; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Thrombolytic Therapy; Tissue Plasminogen Activator; Weight Loss

1993
Phototoxicity of olaquindox in the rat.
    Research in veterinary science, 1990, Volume: 48, Issue:2

    Topics: Animals; Chemical Phenomena; Chemistry; Ear; Edema; Erythema; Male; Molecular Structure; Necrosis; Photosensitivity Disorders; Quinoxalines; Rats; Ultraviolet Rays; Weight Loss

1990